Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-08-01

Clinical Trial Update: Conventional Microneedling vs Microneedling With 5-FU (MMP) for Idiopathic Guttate Hypomelanosis (IGH) Repigmentation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing conventional microneedling to microneedling with 5-FU for repigmentation in idiopathic guttate hypomelanosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5-FU (5-fluorouracil)

Snippet

Sponsor: Clinica Dermatologica Arbache ltda | Conditions: Photosensitivity Disorders | Phase 4 | Status: UNKNOWN